NORTRIPTYLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nortriptyline, and when can generic versions of Nortriptyline launch?
Nortriptyline is a drug marketed by Ani Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Rising, Taro, Teva, Zydus Lifesciences, Pharm Assoc, and Rubicon Research. and is included in eleven NDAs.
The generic ingredient in NORTRIPTYLINE is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nortriptyline
A generic version of NORTRIPTYLINE was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30th, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORTRIPTYLINE?
- What are the global sales for NORTRIPTYLINE?
- What is Average Wholesale Price for NORTRIPTYLINE?
Summary for NORTRIPTYLINE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for NORTRIPTYLINE |
| Drug Sales Revenues: | Drug sales revenues for NORTRIPTYLINE |
| DailyMed Link: | NORTRIPTYLINE at DailyMed |
US Patents and Regulatory Information for NORTRIPTYLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 213441-004 | Feb 24, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 074132-004 | Mar 27, 1995 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharm Assoc | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | SOLUTION;ORAL | 075606-001 | Aug 23, 2000 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
